Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01971957 · ClinicalTrials.gov registry record
Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 20
- Enrollment target
NCT01971957 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 20 participants.
The verdict
NCT01971957 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Sjogren-Larsson syndrome (SLS) is a rare genetic disease in which patients typically exhibit ichthyosis (dry, scaly skin), intellectual disability, spasticity, seizures and a distinctive maculopathy. The purpose of this study is to define the clinical spectrum and natural history of Sjogren-Larsson syndrome, and identify biomarkers that correlate with disease phenotype while establishing a registry for future investigations of biochemical pathogenesis and therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-04-01 |
| Est. Completion | 2023-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01971957
The ClinicalTrials.gov registry entry for NCT01971957 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01971957 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01971957 about?
NCT01971957 is a clinical study titled "Sjogren-Larsson Syndrome: Natural History, Clinical Variation and Evaluation of Biochemical Markers". Sjogren-Larsson syndrome (SLS) is a rare genetic disease in which patients typically exhibit ichthyosis (dry, scaly skin), intellectual disability, spasticity, seizures and a distinctive maculopathy. The purpose of this study is to define the clinical spectrum and natural history of Sjogren-Larsson ...
What is the current status of trial NCT01971957?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2013-04-01. Estimated completion is 2023-09-30.
Who is sponsoring clinical trial NCT01971957?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.